Plasan and Q-Flo Collaborate to Produce CNT Fibers for Vehicle Armor System

Plasan, a global leader in survivability and combat-proven armor solutions and Q-Flo, University of Cambridge spin-out company, today announced the formation of TorTech Nano Fibres Ltd, a joint venture between the two companies.

TorTech, based in Israel, will produce carbon nanotube fiber for the enhancement of body armor and composite armor systems for vehicles. The new material is stronger than Kevlar and other ballistic fabrics, but still flexible and lightweight.

Q-Flo's CEO, Dr. Dai Hayward, commented: "We are delighted to partner with Plasan to further develop the world leading research by Prof. Alan Windle and Dr. Martin Pick, initially within the Department of Materials Science at Cambridge University and for the last 4 years in Q-Flo. Through Tortech, we intend to produce a carbon nanotube-based yarn, which can be woven into the strongest-ever manmade material. Plasan's expertise will then enable the design and production of a revolutionary new range of body and vehicle armor."

CEO of Plasan Group, Dan Ziv, said: "Nano fiber with mechanical properties as carbon nanotube fiber could lead to a breakthrough in structural composites and light weight armor applications. This is an exciting venture since we believe Q-Flo's carbon nanotubes have the potential to revolutionize the defense industry through a new range of lightweight, flexible and incredibly strong armored material."

Plasan will have exclusive sales and marketing rights to defense-orientated materials, whilst Q-Flo will retain rights for other potential applications.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.